Company
Curium
Last checked: Nov 19, 2026Source: Drugs@FDA, ClinicalTrials.gov
NDAs and BLAs
16
11 still marketed
Novel approvals
4
Approvals since 2021
1
Originals and new uses
Phase 3 trials
3
Registered, any status
Trials by phase
All registered drug and biologic trials with this lead sponsor, any status. A public view of the pipeline.
Recent approvals
Originals and efficacy supplements, newest first.
- Bexlutry approved Sep 14, 2026
- Detectnet approved NovelPriority reviewOrphanSep 3, 2020
- Thallous Chloride Tl 201 new use Jul 23, 2004
Drugs in development (0)
Investigational drugs, not yet FDA-approved, in this company's active or recent Phase 2 and 3 trials. Phase 3 first.
No investigational drugs in Phase 2 or 3 trials under this sponsor name.
Recruiting Phase 3 trials
Largest first.
No recruiting Phase 3 trials under this sponsor name.
Marketed drugs (11)
Newest FDA action first.
- Bexlutry Lutetium Lu-177 Dotatate · 2026
- Thallous Chloride Tl 201 Thallous Chloride Tl-201 · 1979
- Technescan Pyp Kit Technetium Tc-99m Pyrophosphate Kit · 1974
- Technescan Hdp Technetium Tc-99m Oxidronate Kit · 1981
- Ultratag Technetium Tc-99m Red Blood Cell Kit · 1991
- Octreoscan Indium In-111 Pentetreotide Kit · 1994
- Detectnet Copper Cu-64 Dotatate · 2020
- Ultra-Technekow V4 Technetium Tc-99m Sodium Pertechnetate Generator · 1973
- Xenon Xe 133 Xenon Xe-133 · 1982
- Technescan Mag3 Technetium Tc-99m Mertiatide Kit · 1990
- Gallium Citrate Ga 67 Gallium Citrate Ga-67 · 1979
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.